Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis

Russell E. Lewis, Sebastian Wurster, Nicholas D. Beyda, Nathaniel D. Albert, Dimitrios P. Kontoyiannis

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

We compared the in vitro pharmacodynamics of isavuconazole, voriconazole, and posaconazole against 92 clinical isolates from documented cases of invasive aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Whereas inhibitory and fungicidal concentrations of these triazoles were predictably similar with the exception of Mucorales, isavuconazole appeared to have improved pharmacodynamics against Fusarium solani.

Original languageEnglish (US)
Article number114861
JournalDiagnostic Microbiology and Infectious Disease
Volume95
Issue number3
DOIs
StatePublished - Nov 2019

Keywords

  • Antifungal therapy
  • Fusariosis
  • Isavuconazole
  • Mold pathogens
  • Mucormycosis
  • Pharmacodynamics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis'. Together they form a unique fingerprint.

Cite this